MARY STEPHENS: Open Payments
NPI 1356836076 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,809 in 90 payments from 16 companies in 2025. Trend: 2023 $1,516 · 2024 $1,894 · 2025 $1,809
Food & beverage: $1,669Education: $140
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $303 |
| GENZYME CORPORATION | 12 | $268 |
| Janssen Biotech, Inc. | 10 | $221 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $218 |
| ABBVIE INC. | 16 | $199 |
| LEO Pharma Inc. | 8 | $172 |
| Galderma Laboratories, L.P. | 11 | $145 |
| Incyte Corporation | 2 | $53 |
| Arcutis Biotherapeutics, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $36 |
Products named: DUPIXENT, TREMFYA, COSENTYX, SKYRIZI, NEMLUVIO, ADBRY, ILUMYA, OPZELURA.
Industry payments across TN — which companies pay providers there.
